HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to ...

HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...

HeartBeam Inc (BEAT) reports a $21 million net loss for 2025 but gains momentum with FDA clearance and strategic partnerships.

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, reported financial and operational results for the fourth quarter ...

Can free AI scanners replace enterprise SAST? Anthropic and OpenAI found 500-plus zero-days pattern-matching tools missed — and both scanners are free.

Fake videos and images depicting fake attacks and fake troops have racked up tens of millions of views on social media ...

HeartBeam, Inc. , a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a strategic collaboration with the Icahn School of Medicine ...

Four-legged robots that scramble up stairs, stride over rubble, and stream inspection data — no preorder, no lab coat required.

A Hong Kong court has ruled that two Tiananmen vigil activists have a case to answer over calls to “end one-party rule” in China in a subversion trial under the Beijing-imposed national security law.

HeartBeam (NASDAQ:BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai aimed at accelerating the development and clinical validation of next-generation artificial ...